Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting

被引：8
|
作者：
Hou, Jiangxue [1 ,2 ]
Li, Yufu [1 ,2 ]
Lin, Quande [1 ,2 ]
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou 450008, Peoples R China
[2] Henan Canc Hosp, Zhengzhou 450008, Peoples R China
来源：
EXPERIMENTAL HEMATOLOGY & ONCOLOGY | 2023年 / 12卷 / 01期
关键词：
Multiple myeloma; Bispecific antibody; CAR T; Clinical trial;
D O I：
10.1186/s40164-023-00436-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Bispecific antibodies (BsAbs) and dual-targeted chimeric antigen receptor T (CAR T) cells have been employed in relapsed/refractory multiple myeloma (RRMM) patients over the past few years, as an increasing number of patients were ineffectively treated by >= 3 prior lines of therapy. BCMA/CD3 and GPRC5D/CD3 are the most popular combinations. Clinical findings indicated that patients exhibit a greater susceptibility to stronger and more enduring responses. Here, we summarize the latest data from the 2023 ASCO annual meeting on BsAbs targeting BCMA/CD3, GPRC5D/CD3 and BCMA/CD19 CAR T cells.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting
    Zheng, Huijian
    Xian, Huajian
    Zhang, Wenjie
    Lu, Chaoqun
    Pan, Renyao
    Liu, Han
    Xu, Zhenshu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2025, 18 (01)
  • [32] Bispecific Antibodies Improve Outcomes in Patients With Relapsed or Refractory Multiple Myeloma After Car-T Cell Therapy
    Merz, Maximilan
    Dima, Danai
    Hashmi, Hamza
    Mueller, Fabian
    Ahmed, Nausheen
    Rathje, Kristin
    Davis, James
    Holderried, Tobias
    Vucinik, Vladan
    Kharbouti, Soraya
    Ayuk, Francis
    Stoelzel, Friedrich
    Schub, Natalie
    Schmitz, Friederike
    Shune, Leyla
    Khouri, Jack
    Anwer, Faiz
    McGuirk, Joseph
    Teichert, Marcel
    von Tresckow, Bastian
    Kroeger, Nicolaus
    Pabst, Thomas
    Abdallah, Al-Ola
    Gagelmann, Nico
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S73 - S74
  • [33] Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
    Xia, Jieyun
    Li, Zhenyu
    Xu, Kailin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [34] Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
    Jieyun Xia
    Zhenyu Li
    Kailin Xu
    Journal of Hematology & Oncology, 16
  • [35] Novel anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma
    Larson, Rebecca C.
    Castano, Ana
    Bouffard, Amanda A.
    Kann, Michael C.
    Schmidts, Andrea
    Gallagher, Kathleen M.
    Maus, Marcela V.
    CANCER RESEARCH, 2022, 82 (12)
  • [36] Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple Myeloma
    Simon, Sylvain
    Riddell, Stanley R.
    BLOOD CANCER DISCOVERY, 2020, 1 (02): : 130 - 133
  • [37] CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting
    Huang, Qiusha
    Zhang, Xiao-hui
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [38] CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting
    Qiusha Huang
    Xiao-hui Zhang
    Delong Liu
    Journal of Hematology & Oncology, 16
  • [39] CAR-T Therapy Versus Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: Systematic Review and Metanalysis of Toxicity and Response
    Mehta, Mansi
    Namjoshi, Devang
    Fernandes, Bolivia Crocete Aloysia
    Mukhtiar, Vaibhavi
    Bhanushali, Charmi
    Kumar, Madhan Srinivasan
    Rana, Gunjan
    Santhi, Jaison Lawrence Alexander
    Mishra, Tanisha
    Ramanathan, Muthalagu
    BLOOD, 2024, 144 : 6929 - 6930
  • [40] Real world outcome of patients with multiple myeloma who received bispecific antibodies after CAR-T therapy.
    Bansal, Radhika
    Corraes, Andre De Menezes Silva
    Brunaldi, Larissa
    Sandahl, Tyler B.
    Matthew, Rees J.
    Hayman, Suzanne R.
    Binder, Moritz
    Abdallah, Nadine
    Dingli, David
    Cook, Joselle
    Gertz, Morie A.
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Warsame, Rahma M.
    Kumar, Shaji
    Lin, Yi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345